Topical Imiquimod 5% cream therapy for external anogenital warts in pregnant women: Report of four cases and review of the literature

References

• Workowski KA, Berman SM; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55:1–94.
   PubMedGoogle Scholar
• Simms I, Fairley CK. Epidemiology of genital warts in England and Wales: 1971 to 1994. Genitourin Med 1997;73:365–367.
   PubMed Web of Science ®Google Scholar
• Beutner KR, Reitano MV, Richwald GA, Wiley DJ. External genital warts: report of the American Medical Association Consensus Conference. AMA Expert Panel on External Genital Warts. Clin Infect Dis 1998;27:796–806.
   PubMed Web of Science ®Google Scholar
• Kemp EA, Hakenewerth AM, Laurent SL, Gravitt PE, Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol 1992;79:649–656.
   PubMed Web of Science ®Google Scholar
• Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL, Hougham AJ, Schmitt KA. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol 1998;134:25–30.
   PubMed Web of Science ®Google Scholar
• O’Mahony C, Law C, Gollnick HP, Marini M. New patient-applied therapy for anogenital warts is rated favourably by patients. Int J STD AIDS 2001;12:565–570.
   PubMed Web of Science ®Google Scholar
• Maw RD. Treatment of external genital warts with 5% imiquimod cream during pregnancy: a case report. BJOG 2004;111:1475.
   PubMed Web of Science ®Google Scholar
• Einarson A, Costei A, Kalra S, Rouleau M, Koren G. The use of topical 5% imiquimod during pregnancy: a case series. Reprod Toxicol 2006;21:1–2.
   PubMed Web of Science ®Google Scholar
• Audisio T, Roca FC, Piatti C. Topical imiquimod therapy for external anogenital warts in pregnant women. Int J Gynaecol Obstet 2008;100:275–276.
   PubMed Web of Science ®Google Scholar
• Public Health Agency of Canada, Canadian Guidelines on Sexually Transmitted Infections. Edition 2006
   Google Scholar
• Australia and New Zealand HPV Project Guidelines for the Management of Genital HPV in Australia and New Zealand 5th Edition – 2007
   Google Scholar
• von Krogh G, Longstaff E. Podophyllin office therapy against condyloma should be abandoned. Sex Transm Infect 2001;77:409–412.
   PubMed Web of Science ®Google Scholar
• Dahl MV. Imiquimod: an immune response modifier. J Am Acad Dermatol 2000;43:S1–S5.
   PubMed Web of Science ®Google Scholar
• Tyring SK, Arany I, Stanley MA, Tomai MA, Miller RL, Smith MH, McDermott DJ, Slade HB. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 1998;178:551–555.
   PubMed Web of Science ®Google Scholar
• Arany I, Tyring SK, Stanley MA, Tomai MA, Miller RL, Smith MH, McDermott DJ, Slade HB. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%. Antiviral Res 1999;43:55–63.
   PubMed Web of Science ®Google Scholar
• Haidopoulos D, Diakomanolis E, Rodolakis A, Vlachos G, Elsheikh A, Michalas S. Safety and efficacy of locally applied imiquimod cream 5% for the treatment of condylomata acuminata of the vulva. Arch Gynecol Obstet 2004;270:240–243.
   PubMedGoogle Scholar
• Moore RA, Edwards JE, Hopwood J, Hicks D. Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis 2001;1:3.
   PubMed Web of Science ®Google Scholar
• Perry CM, Lamb HM. Topical imiquimod: a review of its use in genital warts. Drugs 1999;58:375–390.
   PubMed Web of Science ®Google Scholar
• Edwards L. Imiquimod in clinical practice. J Am Acad Dermatol 2000;43:S12–S17.
   PubMed Web of Science ®Google Scholar
• Manlove-Simmons JM, Zaher FM, Tomai M, Gonik B, Svinarich DM. Effect of imiquimod on cytokine induction in first trimester trophoblasts. Infect Dis Obstet Gynecol 2000;8:105–111.
   PubMedGoogle Scholar
• Centers for disease Control and Prevention. Sexually Transmitted Disease Treatment Guidelines. 2006 MMWR 55 (RR-11) pp. 64.
   Google Scholar
• Tenti P, Zappatore R, Migliora P, Spinillo A, Belloni C, Carnevali L. Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol 1999;93:475–479.
   PubMed Web of Science ®Google Scholar
• Tseng CJ, Liang CC, Soong YK, Pao CC. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstet Gynecol 1998;91:92–96.
   PubMed Web of Science ®Google Scholar
• Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 2003;101:645–652.
   PubMed Web of Science ®Google Scholar
• ACOG Practice Bulletin Clinical Management Guidelines for Obstetricians – Number Gynecologists 61st April 2005.
   Google Scholar